Stock AEON AEON BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company AEON Biopharma, Inc.

Equities

AEON

US00791X1000

Biotechnology & Medical Research

Delayed Nyse
Other stock markets
 12:27:36 2024-05-20 pm EDT 		5-day change 1st Jan Change
1.59 USD +3.92% Intraday chart for AEON Biopharma, Inc. -5.36% -77.92%
May. 09 AEON Biopharma, Inc. Provides Update on Development Pipeline CI
May. 03 US Equity Markets Close Higher Friday Following Weak Jobs Report MT

Business Summary

AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed a Phase II study of ABP-450 for the treatment of cervical dystonia and are conducting a Phase II study of ABP-450 for the treatment of both chronic and episodic migraine.

Number of employees: 10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,122,238 23,415,514 ( 59.85 %) 0 59.85 %

Shareholders

NameEquities%Valuation
Vikram Malik
18.50 %
6,989,163 18.50 % 30 M $
Priveterra Sponsor LLC
18.26 %
6,900,000 18.26 % 29 M $
DAEWOONG CO., LTD.
17.41 %
6,577,604 17.41 % 28 M $
Atalaya Capital Management LP
9.725 %
3,675,000 9.725 % 16 M $
Polar Asset Management Partners, Inc.
9.725 %
3,675,000 9.725 % 16 M $
STRATHSPEY CROWN HOLDINGS GROUP, LLC
5.377 %
2,031,773 5.377 % 9 M $
Vanguard Global Advisers LLC
2.009 %
758,992 2.009 % 3 M $
Ikarian Capital LLC
0.6827 %
257,977 0.6827 % 1 M $
BlackRock Institutional Trust Co. NA
0.6561 %
247,924 0.6561 % 1 M $
Geode Capital Management LLC
0.4753 %
179,595 0.4753 % 763 279 $

Company contact information

AEON Biopharma, Inc.

5 Park Plaza Suite 1750

92614, Irvine

+

http://www.aeonbiopharma.com
address AEON Biopharma, Inc.(AEON)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.53 USD
Average target price
6 USD
Spread / Average Target
+292.16%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
AEON BIOPHARMA, INC. Stock AEON Biopharma, Inc.
-77.92% 59.34M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.72% 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.68% 106B
ARGENX SE Stock argenx SE
-2.59% 21.96B
BIONTECH SE Stock BioNTech SE
-13.30% 21.87B
GENMAB A/S Stock Genmab A/S
-5.29% 19.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.27% 18.08B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.57% 17.71B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.50% 14.32B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.98% 12.42B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. AEON Stock
  4. Company AEON Biopharma, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW